Pharmacogenomics is the research of how genes influence a person’s reaction to drugs. This comparatively new area brings together pharmacology and genomics to create efficient, safe drugs and doses that will be customized to a person’s genetic make-up. Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.
Research: Pharmacoeconomics: Open Access
Research: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Journal of Pharmacognosy & Natural Products
Posters & Accepted Abstracts: Journal of Pharmacognosy & Natural Products
Keynote: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters-Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 